 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Chimerix, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of pharmaceutical products. Its portfolio includes Brincidofovir for the treatment of adenovirus, cytomegalovirus, and smallpox. The company was founded in April 2000 and is headquartered in Durham, NC.

Current Price	$1.39
Prev Close	$1.38
Open	$1.36
Dividend Yield	0.00%
50-Day Moving Average	$1.22
Beta	1.55
Avg. Volume	755,847.42
PE Ratio	0.69

52-Week High	$2.90
52-Week Low	$1.09
Market Capitalization	$122.25M
EPS	$2.00
Price to Book	0.51
Revenue Per Employee	$383,056.18
Enterprise Value/EBITDA	1.71

CMRX Chimerix Inc

About

Feed

Fundamentals

News